Scientists have begun a project to discover how to use DNA to identify the source and track the spread of hospital superbugs. The genetic fingerprints of germs are to be mapped to combat hospital superbugs and help doctors decide what must be done to stop the outbreak. The database will help doctors determine which patients with MRSA and Clostridium difficile have picked up bacteria and therefore control the spread of infection. The germ’s DNA will be sequenced from an MRSA-affected patient and compared with samples in the database to determine whether the infection was present when the patient was admitted to hospital or whether it was acquired on the ward. Data from individual nurses or doctors will be used to discover whether they are spreading disease through poor hygiene, by matching DNA from patients’ germs to samples from the skin or clothing of staff. Be a part of Elets Collaborative Initiatives. Join Us for
Upcoming Events and explore business opportunities. Like us on
Facebook , connect with us on
LinkedIn and follow us on
Twitter ,
Instagram. "Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Related Research
NFHS-6 Reveals India’s Mixed Health Transition: Child Malnutrition Falls, Healthcare Access Improves, But Obesity & Lifestyle Diseases Surge
India’s latest National Family Health Survey (NFHS-6) paints a complex portrait of the country’s public health journ...
P&G Health and IMA Unveil India’s First Evidence-Based Patient Recovery Guidelines Focused on Micronutrients
Strengthening post-illness care in India, Procter & Gamble Health Limited has partnered with the Indian Medical Asso...
30 Years of Scientific Rigour: DiagnoSearch Reinforces Its Role in Accelerating Pharma Pipelines
DiagnoSearch Life Sciences, one of India’s longest-standing and most trusted Clinical Research Organisations (CROs), h...
Servier India Partners with MedGenome & Strand Life Sciences, Expanding AML & CCA Testing
To advance India's precision oncology and equitable access to molecular diagnostics, Servier India, a subsidiary of the ...
One in Four Indians at Risk of Heart Disease as Lipid Imbalances Rise Across Age Groups: Metropolis Study | World Heart Day Special
Metropolis Healthcare Limited, one of India’s largest and most respected pathology networks, has released a nationwide...
IIT Roorkee Scientists Unveil Novel Drug Candidate to Tackle Antibiotic Resistance Crisis
Scientists at the Indian Institute of Technology (IIT) Roorkee have identified a potential drug candidate capable of res...
82% Prefer Diagnostic Centres Over Hospitals in India: ekincare Report
A new data-backed report by ekincare uncovers a decisive change in India’s preventive healthcare landscape, placing di...
Axiom-4 to Test First FDA-Approved Cancer Drug in Space, Pioneering Microgravity-Driven Oncology Research
In a landmark development for pharmaceutical research, the upcoming Axiom-4 (Ax-4) mission is set to test Rebecsinib, th...
Indian Life Sciences Sector Pioneers Future-Ready Lab Design, Setting Global Benchmark: Unispace Survey
A new global survey by Unispace, a leader in workplace strategy, design, and construction, reveals that India's life sci...
Govt Funds ₹330 Cr AI-Healthcare CoE by IIT Delhi & AIIMS Under ‘Make AI Work for India’ Initiative
The Indian Institute of Technology (IIT) Delhi and the All India Institute of Medical Sciences (AIIMS) Delhi have signed...
